GDC-0152

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GDC-0152, covering 2017-06-21 to 2017-06-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety and Pharmacokinetics of GDC-0152, Administered Intravenously to Patients With Locally Advanced or Metastatic Malignancies [Phase 1]

See pricing